Lydian International Limited (TSE:LYD) is getting high-level government support in its fight to restore access to its Amsular project site in Armenia. On Monday, the company told investors that the country’s prime minister Nikol Pashinyan said during a live Facebook broadcast that protesters blocking access to Amsular should open the roads.
CytoDyn Inc (OTCMKTS:CYDY) revealed that the US Food and Drug Administration has given the greenlight to its Phase 2 protocol for a combination therapy of leronlimab and Regorafenib to treat patients with metastatic colorectal cancer. In a statement, the Vancouver, Washington-based late-stage biotechnology company said the FDA had completed its safety review and allowed the company to proceed with its proposed clinical investigation. As a result, the study will be conducted by lead principal investigator John L Marshall, who is an expert in drug development for colon cancer. He is also the chief of the Division of Hematology-Oncology at MedStar Georgetown University Hospital, in Washington.
Pure Gold Mining Inc (TSX.V:PGM) (LSE:PUR) (OTCMKTS:LRTNF) has moved closer to realising cashflow from its exciting Madsen Red Lake gold mine in Ontario and has begun construction. In a statement on Monday, the Vancouver-based firm revealed it had now awarded the surface engineering and procurement (E/P) contract to JDS Energy & Mining (JDS), in partnership with Hatch Ltd (Hatch) and Knight Piesold Ltd (Knight Piesold).
XPhyto Therapeutics Corp (CSE:XPHY) announced Monday that its German subsidiary Bunker Pflanzenextrakte GmbH signed an exclusive cannabis research and development agreement with the Technical University of Munich. The deal was made with the chair of brewing and beverage technology, part of the School of Life Sciences at Weihenstephan, the company said in a statement.
EnWave Corporation (CVE:ENW) announced Monday that it signed a new license agreement in Japan for its proprietary dehydration technology. The company agreed to license its Radiant Energy Vacuum (REV) technology to Kameya Foods Corporation, an agricultural manufacturing company based in Shinshuku, central Japan. Under the terms of the royalty-bearing license, Kameya Foods purchased a 10kW commercial REV machine to kick off commercial production in the Asian nation.
Japan Gold Corp (CVE:JG) has been on an acquisition spree again, announcing Monday that it had acquired five new gold projects, spanning 21,000 hectares, in the east Asian country. The projects are on the island of Kyushu and lie in the southern and middle Kyushu epithermal gold provinces. The firm's portfolio has now been expanded to 24 gold projects across the the largest islands of Japan - Hokkaido, Honshu and Kyushu.
Hillcrest Petroleum Ltd (CVE:HRH) (OTCMKTS:HLRTF), the Western Canada-focused oiler, revealed it is set to bring in up to C$600,000 from a placing at C$0.03 a unit. In a statement on Monday, the Vancouver-headquartered group said it would issue up to 20 million units at that price following a discretionary waiver by the TSX venture exchange of the C$0.05 minimum price requirement.
Nextleaf Solutions Ltd (CSE:OILS) (OTCMKTS:OILFF) received its Standard Processing License from Health Canada, the company announced Monday, which will allow it to begin production of its intellectual property portfolio. The company has a roster of four issued and 25 pending patents centered around the industrial extraction of cannabis oils and the purification of cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD).
The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCMKTS:TGODF) and Caliper Foods unveiled positive results Monday from a preliminary human pharmacokinetic study of Caliper CBD, a proprietary water-soluble powder that can be added to food and beverages. In a statement, TGOD said it will commercialize organic CBD dissolvables in Canada in December through “fast-acting formulations” leveraging the technology with its lineup of organic teas, shots, chewables, and ready-to-drink beverages. Similarly, in the US, Caliper Foods plans to release Caliper CBD, its own line of precision-dosed CBD dissolvables in the Fall.
Blackrock Gold Corporation (CVE:BRC) has closed a major funding package to support a new drilling program at the Silver Cloud property in Nevada. The Vancouver-based company told shareholders that it had completed a C$1.02 million financing last week, an over-subscribed private placement announced on August 13. The explorer increased the size of the non-brokered private placement, issuing nearly 6.4 million units of the company at a price of C$0.16 for total proceeds of C$1,020,820.
American Battery Metals Corporation (OTCQB:ABML) CEO Doug Cole told investors Monday that the company will finish 2019 in a “remarkably strong position,” while laying the groundwork for the next year. In a statement, the company said the initial results and comprehensive analysis at depths down to 3,000 feet was “positive,” inspiring an ambitious drill program to include up to 20 holes over the next 12 months, with three more holes planned for the fourth quarter.
Orgenesis Inc. (NASDAQ:ORGS), a leading cell and gene therapy enabling company providing centralized CDMO manufacturing and development services through its subsidiary MTH Global, Inc., as well as localized point-of-care development and processing centers, announced that its chief executive officer, Vered Caplan will present at the 2019 Janney Healthcare Conference on Tuesday, September 10th at 12:35 pm Eastern Time. The conference is being held September 9-10, 2019 at The Union League Club in New York City.
Telson Mining Corporation said it will be attending the 2019 Precious Metals Summit being held at the Beaver Creek Resort in Colorado from September 10 to 13, 2019. It added that a webcast of Telson president, Ralph Shearing's presentation on Friday, September 13 at 11:30am EST will be available.
Carube Copper Corp (CVE:CUC) said the TSX Venture Exchange has accepted for filing documentation with respect to the non-brokered private placement it announced on July 15, 2019. The group said it will issue 5.2 million shares at a price of 5 cents plus 5.2 million warrants to purchase 5.2 million shares at an exercise price of 8 cents for a three-year period, with six placees.
Acasti Pharma Inc (CVE:ACST) (NASDAQ:ACST) announced Monday that the Canadian government will give the company $750,000 to help further develop its flagship prescription drug candidate CaPre. In a statement, the biopharmaceutical company said the support from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) will allow it to expand and enhance its production capabilities for CaPre. The drug is designed to combat severe hypertriglyceridemia, a metabolic condition that contributes to increased risk of cardiovascular disease and pancreatitis.
TIMIA Capital Corporation (CVE:TCA) (OTCMKTS:TIMCF) announced Monday that its shares have begun trading on the OTCQB market in the US Shares of Vancouver-based TIMIA will trade on OTC markets under the symbol ‘TIMCF,’ in addition to its listing on the TSX Venture Exchange. The technology investment company also applied to the Depository Trust Company (DTC) for eligibility, a move that will reduce costs and simplify the trading process on the OTCQB.
Klondike Gold Corp (CVE:KG) said the TSX Venture Exchange has accepted for filing documentation with respect to the non-brokered private placement it announced on September 3, 2019. The placement, with 13 placees, will see 1,925,000 flow-through shares issued at a purchase price of 40 cents each, plus 925,500 share purchase warrants to purchase 925,500 shares at an exercise price of 50 cents for a three-year period.
GlobeX Data Ltd. (CSE:SWIS) (CSE:SWIS.WT) revealed that on August 30th 2019 its CEO, Alain Ghiai, was a guest on ICI Radio Canada Alberta discussing the latest privacy breached which potentially affected 7000 patients in Alberta, Canada. The interview can be listened to on the following site and link: https://globexdatagroup.com/media-and-press/alain-ghiai-ceo-of-globex-data-ltd-is-interviewed-on-le-cafe-show-hosted-by-rudy-desjardins-airing-on-ici-radio-canada-aug-30-2019
Genprex confirmed it will be presenting at the H.C. Wainwright 21st Annual Global Investment Conference on Monday, September 9, 2019, from 12:30-12:55 pm EDT in New York City. Genprex’s chairman and chief executive officer, Rodney Varner, will lead the company's presentation in the Adams room and will be available for one-on-one meetings, the group added.